Adria Cimino
TMFAdriaCimino
Adria Cimino is a contributing Motley Fool stock market analyst covering healthcare, technology, and consumer goods sectors. Prior to The Motley Fool, Adria covered the European stock market and U.S. stocks pre-market trading for Bloomberg News, Bloomberg TV, and Bloomberg Radio for more than a decade. Earlier in her career, she wrote about biotech, medtech, and technology companies in Boston for Mass High Tech, an American City Business Journals publication. She holds a bachelor’s degree in mass communications from the University of South Florida.
Recent Articles by Adria Cimino

Apr 27, 2025
by Adria Cimino
Should You Buy Palantir Before May 5?

Apr 24, 2025
by Adria Cimino
AWS Just Delivered Great News for Nvidia Shareholders

Apr 24, 2025
by Adria Cimino
Tariff Turbulence: How Risky Are Tech Stocks Right Now?

Apr 24, 2025
by Adria Cimino
Is Intuitive Surgical Stock a Buy?

Apr 23, 2025
by Adria Cimino
2 No-Brainer Warren Buffett Stocks to Buy Right Now

Apr 21, 2025
by Adria Cimino
Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Apr 20, 2025
by Adria Cimino
1 Growth Stock Down 20% to Buy Right Now

Apr 20, 2025
by Adria Cimino
Where Will Moderna Be in 5 Years?

Apr 18, 2025
by Adria Cimino
2 No-Brainer AI Stocks to Buy Right Now

Apr 17, 2025
by Adria Cimino
The Best Stocks to Invest $50,000 In Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.